Alpha 2.0
Login Register
» Authors » P Borro

P Borro

Explore the profile of P Borro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 308
Followers 0
Related Specialties
Gastroenterology
General Medicine
Pharmacology
Top 10 Co-Authors
G Testino
R Testa
S Leone
V Savarino
C Mansi
F Botta
E Giannini
E Testa
A FASOLI
D Risso
Published In
Aliment Pharmacol Ther
Minerva Med
Diabetes Metab
J Interferon Cytokine Res
J Dent Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Alcohol and disease prevention
Testino G, Leone S, Borro P
Diabetes Metab . 2015 Jul; 41(6):520. PMID: 26159381
No abstract available.
2.
Treatment of alcohol dependence: recent progress and reduction of consumption
Testino G, Leone S, Borro P
Minerva Med . 2014 Nov; 105(6):447-66. PMID: 25392958
Alcohol dependence (AD) is a major public health problem. Currently, three drugs for the treatment of AD have been approved by both the European Medicines Agency (EMA) and the Food...
3.
Treatment of alcoholic very early hepatocellular carcinoma: role of percutaneous ablation. Beyond Barcellona criteria
Borro P, Scudeletti M, Testino G
Minerva Chir . 2014 Mar; 69(1):57-8. PMID: 24675246
No abstract available.
4.
Moderate alcohol use and health: a nonsense
Testino G, Patussi V, Leone S, Scafato E, Borro P
Nutr Metab Cardiovasc Dis . 2014 Jan; 24(1):e4-5. PMID: 24418383
No abstract available.
5.
Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view
Testino G, Leone S, Ansaldi F, Borro P
Minerva Gastroenterol Dietol . 2013 Nov; 59(4):341-56. PMID: 24212353
The alcoholic liver disease (ALD) is the leading cause of death from liver failure in Italy and worldwide. Ethanol abstention, a healthy diet, and a significant improvement of life-style are...
6.
Recurrent hepatitis C and non-alcoholic fatty liver disease in transplanted patients: a review
Testino G, Sumberaz A, Leone S, Borro P
Minerva Med . 2013 Mar; 104(2):225-32. PMID: 23514999
Non-alcoholic fatty liver disease (NAFLD) is a common occurrence after orthotopic liver transplantation (OLT). The association steatosis/HCV determines important implications for clinical practice: steatosis accelerates the progression of fibrosis and...
7.
Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt
Testino G, Leone S, Ferro C, Borro P
J Med Life . 2012 Jul; 5(2):203-5. PMID: 22802893
Acute Alcoholic Hepatitis (AAH) is a syndrome of progressive inflammatory liver injury associated with long-term heavy intake of ethanol. Mild to moderate forms of AAH frequently respond to alcoholic abstinence,...
8.
Human carcinogenesis and alcohol in hepato-gastroenterology
Testino G, Borro P, Ancarani O, Sumberaz A
Eur Rev Med Pharmacol Sci . 2012 Jun; 16(4):512-8. PMID: 22696879
Alcohol consumption is one of the top-10 risks for worldwide burden of disease. The International Agency for Research for Cancer affirmed that there was evidence for the carcinogenicity of ethanol...
9.
Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass index
Testino G, Gentile R, Ansaldi F, Borro P, Ravetti G, Icardi G, et al.
Panminerva Med . 2009 Sep; 51(2):135-6. PMID: 19776716
No abstract available.
10.
Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index
Testa R, Testa E, Giannini E, Borro P, Milazzo S, Isola L, et al.
J Intern Med . 2006 Aug; 260(2):142-50. PMID: 16882278
Objectives: Noninvasive evaluation of fibrosis is an on-going effort in the management of chronic hepatitis C. This study was planned to noninvasively evaluate fibrosis staging. Design: We evaluated the biochemical,...